All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

324

Reset

324 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • BPI-572270Phase 21 trial

    Betta Pharmaceuticals Co., Ltd. · Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC)

  • CBX-12Phase 21 trial

    Cybrexa Therapeutics · Solid Tumor, Adult, Epithelial Ovarian Cancer, Small Cell Lung Carcinoma

  • CKD-703Phase 21 trial

    Chong Kun Dang Pharmaceutical · Advanced Solid Tumors, Non-Small Cell Lung Cancer

  • CP-383Phase 21 trial

    Tasca Therapeutics · Solid Tumor Malignancies, Colorectal Carcinoma, Small Cell Lung Cancer ( SCLC )

  • CR-002Phase 21 trial

    Crescent Biopharma, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M), Gastric/GEJ, Biliary Tract Cancer (BTC)

  • DanvatirsenAZD9150Phase 21 trial

    AstraZeneca · Non-Small Cell Lung Cancer

  • DC05F01Phase 21 trial

    Heronova Pharmaceuticals · Solid Tumors, Ovarian Cancer, Small Cell Lung Cancer

  • Decoy20Phase 21 trial

    Indaptus Therapeutics, Inc · Solid Tumor, Adult, HCC - Hepatocellular Carcinoma, CRC (Colorectal Cancer)

  • DJI136Phase 21 trial

    Novartis · Extensive-stage Small Cell Lung Cancer (ES-SCLC)

  • DS-1103aPhase 21 trial

    Daiichi Sankyo · Solid Tumor, Locally Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer

  • DXC006Phase 21 trial

    Hangzhou DAC Biotechnology Co., Ltd. · Small Cell Lung Cancer

  • ECI830Phase 21 trial

    Novartis · Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Extensive-stage Small Cell Lung Cancer

  • EfineptakinNT-I7, rhIL-7-hyFcPhase 21 trial

    NeoImmuneTech · Any Advanced Solid Tumors, Triple Negative Breast Cancer, Non Small Cell Lung Cancer

  • ENV-501Phase 21 trial

    Hummingbird Bioscience · Melanoma (Skin), Non Small Cell Lung Cancer, Breast Cancer

  • ES102Phase 21 trial

    Elpiscience (Suzhou) Biopharma, Ltd. · Non-Small Cell Lung Cancer

  • ETX-929Phase 21 trial

    Ensem Therapeutics · Metastatic Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC), Non-squamous, Non-Small Cell Lung Cancer

  • FF-10832Gemcitabine LiposomePhase 21 trial

    Fujifilm Pharmaceuticals U.S.A., Inc. · Advanced Urothelial Carcinoma, Advanced Non Small Cell Lung Cancer

  • gavo-celPhase 21 trial

    TCR2 Therapeutics · Mesothelioma, Mesothelioma, Malignant, Mesothelioma; Pleura

  • GEN-725Phase 21 trial

    Henan Genuine Biotech Co., Ltd. · Non-Small Cell Lung Cancer

  • GEN1042Phase 21 trial

    Genmab · Malignant Solid Tumor, Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC)

  • GFH925Phase 21 trial

    Genfleet Therapeutics (Shanghai) Inc. · Advance Non-small Cell Lung Cancer

  • GI-101Phase 21 trial

    GI Innovation, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Cervical Cancer

  • GI-101APhase 21 trial

    GI Innovation, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Cervical Cancer

  • GI-108Phase 21 trial

    GI Innovation, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Non-small Cell Lung Cancer (NSCLC)

  • GTAEXS617REC-617Phase 21 trial

    Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC), Pancreatic Adenocarcinoma, Non-small Cell Lung Cancer (NSCLC)

  • HMBD-001Phase 21 trial

    Hummingbird Bioscience · Advanced or Metastatic Squamous Non-Small Cell Lung Cancer, Advanced Head and Neck Squamous Cell Carcinoma, Advanced Esophageal Squamous Cell Carcinoma

  • IAM1363Phase 21 trial

    Iambic Therapeutics, Inc · HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer

  • IDE161Phase 21 trial

    IDEAYA Biosciences · Small-cell Lung Cancer, Neuroendocrine Carcinomas, Solid Tumor Show to Express DLL3

  • IDE397Phase 21 trial

    Amgen · MTAP-null Non-Small-Cell Lung Cancer, MTAP-null Solid Tumors

  • IDE849Phase 21 trial

    IDEAYA Biosciences · Small-cell Lung Cancer, Neuroendocrine Carcinomas, Solid Tumor Show to Express DLL3

  • IDP-001Phase 21 trial

    InduPro, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Head and Neck Squamous Cell Carcinoma

  • ILKN421HPhase 21 trial

    iLeukon Therapeutics, Inc. · Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

  • IMT-009Phase 21 trial

    Immunitas Therapeutics · Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Triple Negative Breast Cancer

  • INV-8989Phase 21 trial

    Shenzhen Ionova Life Sciences Co., Ltd. · Advance Solid Tumors, Colon and Rectal Cancer, Non - Small Cell Lung Cancer NSCLC

  • IOV-4001Phase 21 trial

    Iovance Biotherapeutics, Inc. · Unresectable Melanoma, Metastatic Melanoma, Stage III Non-small Cell Lung Cancer

  • IOV-5001Phase 21 trial

    Iovance Biotherapeutics, Inc. · Advanced Solid Tumors, Non-Small Cell Lung Cancer, Triple Negative Breast Cancer (TNBC)

  • IPH5201Phase 21 trial

    Innate Pharma · Non Small Cell Lung Cancer

  • JAB-2485Aurora A inhibitorPhase 21 trial

    Jacobio Pharmaceuticals Co., Ltd. · Solid Tumors, ER+ Breast Cancer, Triple Negative Breast Cancer, TNBC

  • JMT203Phase 21 trial

    Shanghai JMT-Bio Inc. · Non Small Cell Lung Cancer, Pancreatic Cancer, Cancer Cachexia

  • JYP0015Phase 21 trial

    Guangzhou JOYO Pharma Co., Ltd · Solid Tumor, Pancreatic Ductal Adenocarcinoma (PDAC), Non-small Cell Lung Cancer (NSCLC)

  • KeynatinibTL007Phase 21 trial

    Medolution Ltd. · Non-Small Cell Lung Cancer With EGFR Mutation, Brain Metastases

  • LG00313112Phase 21 trial

    LG Chem · Ovarian Cancer, Small Cell Lung Cancer, Non Small Cell Lung Cancer

  • MT-4561Phase 21 trial

    Tanabe Pharma America, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC), Non-small Cell Lung Cancer (NSCLC), Esophageal Cancer

  • NDI-101150Phase 21 trial

    Nimbus Saturn, Inc. · Solid Tumor, Renal Cell Carcinoma (Kidney Cancer), Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma

  • NEO-201Phase 21 trial

    Precision Biologics, Inc · Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Cervical Cancer

  • NHT102Phase 21 trial

    Nob Hill Therapeutics, Inc. · NSCLC (Advanced Non-small Cell Lung Cancer)

  • OBX-115Phase 21 trial

    Obsidian Therapeutics, Inc. · Tumor Skin, Metastatic Melanoma, Melanoma

  • OR502Phase 21 trial

    OncoResponse, Inc. · Cancer, Tumor, Solid, Malignant Neoplasm

  • OSE-279Phase 21 trial

    OSE Immunotherapeutics · Solid Advanced Tumor, Lymphoma, NSCLC (Non-small Cell Lung Cancer)

  • PF-0704091Phase 21 trial

    Pfizer · Small Cell Lung Cancer, Ovarian Cancer, Breast Cancer

NewerPage 6 of 7Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.